G protein-coupled receptor signaling in cardiac nuclear membranes

Journal of Cardiovascular Pharmacology

Volumn 65, Issue 2, 2015, Pages 101-109

  Branco, Ana F ^a,b   Allen, Bruce G ^a,b,c  

^a MONTREAL HEART INSTITUTE   (Canada)

^b Departments of Biochemistry   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

cardiomyocyte; GPCR; heart; intracrine signaling; nucleus; transcriptome

Indexed keywords

ANGIOTENSIN II; BETA ADRENERGIC RECEPTOR; ENDOTHELIN; G PROTEIN COUPLED RECEPTOR; ADRENERGIC RECEPTOR; ANGIOTENSIN RECEPTOR; CARDIOVASCULAR AGENT; ENDOTHELIN RECEPTOR; LIGAND;

CARDIOVASCULAR FUNCTION; CELL FUNCTION; CELL NUCLEUS MEMBRANE; CELL SURFACE; HEART MUSCLE CELL; HUMAN; IMMUNOREACTIVITY; LIGAND BINDING; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; CARDIAC MUSCLE CELL; CARDIOVASCULAR SYSTEM; DRUG DEVELOPMENT; DRUG EFFECTS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

CARDIOVASCULAR AGENTS; CARDIOVASCULAR SYSTEM; DRUG DISCOVERY; HUMANS; LIGANDS; MYOCYTES, CARDIAC; NUCLEAR ENVELOPE; RECEPTORS, ADRENERGIC; RECEPTORS, ANGIOTENSIN; RECEPTORS, ENDOTHELIN; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84922732076     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0000000000000196     Document Type: Review

References (141)

1. Tadevosyan A, Vaniotis G, Allen BG, et al. G protein-coupled receptor signaling in the cardiac nuclear membrane: evidence and possible roles in physiological and pathophysiological function. J Physiol. 2012;590 (pt 6):1313-1330.
2. Re RN, Vizard DL, Brown J, et al. Angiotensin II receptors in chromatin. J Hypertens. 1984;2:S271-S273.
3. Booz GW, Conrad KM, Hess AL, et al. Angiotensin-II binding sites on hepatocyte nuclei. Endocrinology. 1992;130:3641-3649.
4. Tadevosyan A, Maguy A, Villeneuve LR, et al. Nuclear-delimited angiotensin receptor-mediated signaling regulates cardiomyocyte gene expression. J Biol Chem. 2010;295:22338-22349.
5. Savard M, Barbaz D, Belanger S, et al. Expression of endogenous nuclear bradykinin B2 receptors mediating signaling in immediate early gene activation. J Cell Physiol. 2008;216:234-244.
6. Wright CD, Chen Q, Baye NL, et al. Nuclear a1-adrenergic receptors signal activated ERK localization to caveolae in adult cardiac myocytes. Circ Res. 2008;103:992-1000.
7. Wright CD, Wu SC, Dahl EF, et al. Nuclear localization drives a1-adrenergic receptor oligomerization and signaling in cardiac myocytes. Cell Signal. 2012;24:794-802.
8. Boivin B, Lavoie C, Vaniotis G, et al. Functional b-adrenergic receptor signaling on nuclear membranes in adult rat and mouse ventricular cardiomyocytes. Cardiovasc Res. 2006;71:69-78.
9. Vaniotis G, Del Duca D, Trieu P, et al. Nuclear b-adrenergic receptors modulate gene expression in adult rat heart. Cell Signal. 2011;23:89-98.
10. Boivin B, Chevalier D, Villeneuve LR, et al. Functional endothelin receptors are present on nuclei in cardiac ventricular myocytes. J Biol Chem. 2003;278:29153-29163.
11. Carpentier IL, Rees AR, Gregoriou M, et al. Subcellular distribution of the external and interanl domains of the EGF receptor in A-431 cells. Exp Cell Res. 1986;166:312-326.
12. Srinivasan R, Gillett CE, Barnes DM, et al. Nuclear expression of the c-erbB-4/HER-4 growth factor receptor in invasive breast cancer. Cancer Res. 2000;60:1483-1487.
13. Stachowiak MK, Maher PA, Joy A, et al. Nuclear accumulation of fibroblast growth factor receptors is regulated by multiple signals in adrenal medullary cells. Mol Biol Cell. 1996;7:1299-1317.
14. Horvat A. Insulin binding sites on rat liver nuclear membranes: biochemical and immunological studies. J Cell Physiol. 1978;97:37-47.
15. Vigneri R, Goldfine ID, Wong KY, et al. The nuclear envelope. The major site of insulin binding in rat liver nuclei. J Biol Chem. 1978;253: 2098-2103.
16. Kushnaryov VM, MacDonald HS, Sedmak JJ, et al. Murine interferonbeta receptor-mediated endocytosis and nuclear membrane binding. Proc Natl Acad Sci USA. 1985;82:3281-3285.
17. Lind GJ, Cavanagh HD. Nuclear muscarinic acetylcholine receptors in corneal cells from rabbit. Invest Ophthalmol Vis Sci. 1993;34: 2943-2952.
18. Yankner BA, Shooter EM. Nerve growth factor in the nucleus: interaction with receptors on the nuclear membrane. Proc Natl Acad Sci USA. 1979;76:1269-1273.
19. Jacques D, Sader S, Perreault C, et al. Presence of neuropeptide Y and the Y1 receptor in the plasma membrane and nuclear envelope of human endocardial endothelial cells: modulation of intracellular calcium. Can J Physiol Pharmacol. 2003;81:288-300.
20. Bhattacharya M, Peri KG, Almazan G, et al. Nuclear localization of prostaglandin E2 receptors. Proc Natl Acad Sci USA. 1998;95:15792-15797.
21. Bhattacharya M, Peri K, Ribeiro-da-Silva A, et al. Localization of functional prostaglandin E2 receptors EP3 and EP4 in the nuclear envelope. J Biol Chem. 1999;274:15719-15724.
22. Gobeil F Jr, Bernier SG, Vazquez-Tello A, et al. Modulation of proinflammatory gene expression by nuclear lysophosphatidic acid receptor type-1. J Biol Chem. 2003;278:38875-38883.
23. Doan ND, Nguyen TT, Letourneau M, et al. Biochemical and pharmacological characterization of nuclear urotensin-II binding sites in rat heart. Br J Pharmacol. 2012;166:243-257.
24. Nguyen TT, Letourneau M, Chatenet D, et al. Presence of urotensin-II receptors at the cell nucleus: specific tissue distribution and hypoxiainduced modulation. Int J Biochem Cell Biol. 2012;44:639-647.
25. Belcheva M, Barg J, Rowinski J, et al. Novel opioid binding sites associated with nuclei of NG-108-15 neurohybrid cells. J Neurosci. 1993;13:104-114.
26. Re RN, MacPhee AA, Fallon JT. Specific nuclear binding of angiotensin II by rat liver and spleen nuclei. Clin Sci (Lond). 1981;61(suppl 7): 245s-247s.
27. Tang SS, Rogg H, Schumacher R, et al. Characterization of nuclear angiotensin-II-binding sites in rat liver and comparison with plasma membrane receptors. Endocrinology. 1992;131:374-380.
28. Eggena P, Zhu JH, Sereevinyayut S, et al. Hepatic angiotensin II nuclear receptors and transcription of growth-related factors. J Hypertens. 1996;14:961-968.
29. Licea H, Walters MR, Navar LG. Renal nuclear angiotensin II receptors in normal and hypertensive rats. Acta Physiol Hung. 2002;89: 427-438.
30. Pendergrass KD, Averill DB, Ferrario CM, et al. Differential expression of nuclear AT1 receptors and angiotensin II within the kidney of the male congenic mRen2. Lewis rat. Am J Physiol Renal Physiol. 2006; 290:F1497-F1506.
31. Lu D, Yang H, Shaw G, et al. Angiotensin II-induced nuclear targeting of the angiotensin type 1 (AT1) receptor in brain neurons. Endocrinology. 1998;139:365-375.
32. Fu ML, Schulze W, Wallukat G, et al. Immunohistochemical localization of angiotensin II receptors (AT1) in the heart with anti-peptide antibodies showing a positive chronotropic effect. Receptors Channels. 1998;6:99-111.
33. Gwathmey TM, Shaltout HA, Pendergrass KD, et al. Nuclear angiotensin II type 2 (AT2) receptors are functionally linked to nitric oxide production. Am J Physiol. 2009;296:F1484-F1493.
34. Gwathmey TM, Pendergrass KD, Reid SD, et al. Angiotensin-(1-7)-angiotensin-converting enzyme 2 attenuates reactive oxygen species formation to angiotensin II within the cell nucleus. Hypertension. 2010;55:166-171.
35. Hocher B, Rubens C, Hensen J, et al. Intracellular distribution of endothelin-1 receptors in rat liver cells. Biochem Biophys Res Commun. 1992;184:498-503.
36. Bkaily G, Choufani S, Hassan G, et al. Presence of functional endothelin-1 receptors in nuclear membranes of human aortic vascular smooth muscle cells. J Cardiovasc Pharmacol. 2000;36(5 suppl 1): S414-S417.
37. Bkaily G, Massaad D, Choufani S, et al. Role of endothelin-1 receptors in the sarcolemma membrane and the nuclear membrane in the modulation of basal cytosolic and nuclear calcium levels in heart cells. Clin Sci (Lond). 2002;103(suppl 48):141S-147S.
38. Boivin B, Villeneuve LR, Farhat N, et al. Subcelluar distribution of endothelin signaling pathway components in ventricular myocytes and heart: lack of preformed caveolar signalosomes. J Mol Cell Cardiol. 2005;38:665-676.
39. Liu T, Long L, Tang T, et al. Expression and localization of endothelin-1 and its receptors in the spiral ganglion neurons of mouse. Cell Mol Neurobiol. 2009;29:739-745.
40. Merlen C, Farhat N, Luo X, et al. Intracrine endothelin signaling evokes IP3-dependent increases in nucleoplasmic Ca2+ in adult cardiac myocytes. J Mol Cell Cardiol. 2013;62:189-202.
41. Fareh J, Touyz RM, Schiffrin EL, et al. Endothelin-1 and angiotensin II receptors in cells from rat hypertrophied heart. Receptor regulation and intracellular Ca2+ modulation. Circ Res. 1996;78:302-311.
42. Allen BG, Farhat H, Phuong LL, et al. Both endothelin-A and endothelin-B receptors are present on adult rat cardiac ventricular myocytes. Can J Physiol Pharmacol. 2003;81:95-104.
43. Galougahi KK, Liu CC, Bundgaard H, et al. B-Adrenergic regulation of the cardiac Na+-K+ ATPase mediated by oxidative signaling. Trends Cardiovasc Med. 2012;22:83-87.
44. Chen R, Mukhin YV, Garnovskaya MN, et al. A functional angiotensin II receptor-GFP fusion protein: evidence for agonist-dependent nuclear translocation. Am J Physiol Ren Physiol. 2000;279:F440-F448.
45. Lee DK, Lanca AJ, Cheng R, et al. Agonist-independent nuclear localization of the apelin, angiotensin AT1, and bradykinin B2 receptors. J Biol Chem. 2004;279:7901-7908.
46. Sakurai T, Yanagisawa M, Takuwa Y, et al. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 1990;348:732-735.
47. Bousso-Mittler D, Galron R, Sokolovsky M. Endothelin/sarafotoxin receptor heterogeneity: evidence for different glycosylation in receptors from different tissues. Biochem Biophys Res Commun. 1991;178:921-926.
48. Sokolovsky M, Ambar I, Galron R. A novel subtype of endothelin receptors. J Biol Chem. 1992;267:20551-20554.
49. Abe Y, Nakayama K, Yamanaka A, et al. Subtype-specific trafficking of endothelin receptors. J Biol Chem. 2000;275:8664-8671.
50. Morinelli TA, Raymond JR, Baldys A, et al. Identification of a putative nuclear localization sequence within ANG II AT1A receptor associated with nuclear activation. Am J Physiol Cell Physiol. 2007;292:C1398-C1408.
51. Kosugi S, Hasebe M, Tomita M, et al. Systematic identification of cell cycle-dependent yeast nucleocytoplasmic shuttling proteins by prediction of composite motifs. Proc Natl Acad Sci USA. 2009;106:10171-10176.
52. Bkaily G, Avedanian L, Al-Khoury J, et al. Nuclear membrane receptors for ET-1 in cardiovascular function. Am J Physiol Regul Integr Comp Physiol. 2011;300:R251-R263.
53. Carey RM. Functional intracellular renin-angiotensin systems: potential for pathophysiology of disease. Am J Physiol Regul Integr Comp Physiol. 2012;302:R479-R481.
54. Cook JL, Re RN. Lessons from in vitro studies and a related intracellular angiotensin II transgenic mouse model. Am J Physiol Regul Integr Comp Physiol. 2012;302:R482-R493.
55. Ellis B, Li XC, Miguel-Qin E, et al. Evidence for a functional intracellular angiotensin system in the proximal tubule of the kidney. Am J Physiol Regul Integr Comp Physiol. 2012;302:R494-R509.
56. Gwathmey TM, Alzayadneh EM, Pendergrass KD, et al. Novel roles of nuclear angiotensin receptors and signaling mechanisms. Am J Physiol Regul Integr Comp Physiol. 2012;302:R518-R530.
57. Re RN, Cook JL. Noncanonical intracrine action. J Am Soc Hypertens. 2011;5:435-448.
58. Vaniotis G, Allen BG, Hébert TE. Nuclear GPCRs in cardiomyocytes: an insider's view of b-adrenergic receptor signaling. Am J Physiol Heart Circ Physiol. 2011;301:H1754-H1764.
59. Zhuo JL, Li XC. New insights and perspectives on intrarenal reninangiotensin system: focus on intracrine/intracellular angiotensin II. Peptides. 2011;32:1551-1565.
60. Gobeil F Jr, Dumont I, Marrache AM, et al. Regulation of eNOS expression in brain endothelial cells by perinuclear EP3 receptors. Circ Res. 2002;90:682-689.
61. Ryall KA, Saucerman JJ. Automated imaging reveals a concentration dependent delay in reversibility of cardiac myocyte hypertrophy. J Mol Cell Cardiol. 2012;53:282-290.
62. Wu SC, Dahl EF, Wright CD, et al. Nuclear localization of a1A-adrenergic receptors is required for signaling in cardiac myocytes: an "inside-out" a1-AR signaling pathway. J Am Heart Assoc. 2014;3:e000145.
63. Buu NT, Hui R, Falardeau P. Norepinephrine in neonatal rat ventricular myocytes: association with the cell nucleus and binding to nuclear alpha 1-and beta-adrenergic receptors. J Mol Cell Cardiol. 1993;25:1037-1046.
64. Vaniotis G, Glazkova I, Merlen C, et al. Regulation of cardiac nitric oxide signaling by nuclear b-adrenergic and endothelin receptors. J Mol Cell Cardiol. 2013;62:58-68.
65. Xiao RP, Zhu W, Zheng M, et al. Subtype-specific alpha1-and betaadrenoceptor signaling in the heart. Trends Pharmacol Sci. 2006;27:330-337.
66. Belge C, Hammond J, Dubois-Deruy E, et al. Enhanced expression of b3-adrenoceptors in cardiac myocytes attenuates neurohormoneinduced hypertrophic remodeling through nitric oxide synthase. Circulation. 2014;129:451-462.
67. Bristow MR, Ginsburg R, Minobe W, et al. Decreased catecholamine sensitivity and b-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982;307:205-211.
68. Moniotte S, Kobzik L, Feron O, et al. Upregulation of b3-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation. 2001;103:1649-1655.
69. Suzuki T, Kumazaki T, Mitsui Y. Endothelin-1 is produced and secreted by neonatal rat cardiac myocytes in vitro. Biochem Biophys Res Commun. 1993;191:823-830.
70. Thomas PB, Liu EC, Webb ML, et al. Exogenous effects and endogenous production of endothelin in cardiac myocytes: potential significance in heart failure. Am J Physiol. 1996;271(6 pt 2):H2629-H2637.
71. Yanagisawa H, Hammer RE, Richardson JA, et al. Disruption of ECE-1 and ECE-2 reveals a role for endothelin-converting enzyme-2 in murine cardiac development. J Clin Invest. 2000;105:1373-1382.
72. Ergul A, Walker CA, Goldberg A, et al. ET-1 in the myocardial interstitium: relation to myocyte ECE activity and expression. Am J Physiol Heart Circ Physiol. 2000;278:H2050-H2056.
73. Rodriguez-Pascual F, Busnadiego O, Lagares D, et al. Role of endothelin in the cardiovascular system. Pharmacol Res. 2011;63:463-472.
74. Stow LR, Jacobs ME, Wingo CS, et al. Endothelin-1 gene regulation. FASEB J. 2011;25:25-28.
75. Yamazaki T, Komuro I, Kudoh S, et al. Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy. J Biol Chem. 1996;271:3221-3228.
76. Maeda S, Miyauchi T, Sakai S, et al. Prolonged exercise causes an increase in endothelin-1 production in the heart in rats. Am J Physiol. 1998;275(6 pt 2):H2105-H2112.
77. Iemitsu M, Maeda S, Otsuki T, et al. Time course alterations of myocardial endothelin-1 production during the formation of exercise training-induced cardiac hypertrophy. Exp Biol Med (Maywood). 2006;231:871-875.
78. Maki S, Miyauchi T, Sakai S, et al. Endothelin-1 expression in hearts of transgenic hypertensive mice overexpressing angiotensin II. J Cardiovasc Pharmacol. 1998;31(suppl 1):S412-S416.
79. Yorikane R, Sakai S, Miyauchi T, et al. Increased production of endothelin-1 in the hypertrophied rat heart due to pressure overload. FEBS Lett. 1993;332:31-34.
80. Arai M, Yoguchi A, Iso T, et al. Endothelin-1 and its binding sites are upregulated in pressure overload cardiac hypertrophy. Am J Physiol. 1995;268:H2084-H2091.
81. Sakai S, Yorikane R, Miyauchi T, et al. Altered production of endothelin-1 in the hypertrophied rat heart. J Cardiovasc Pharmacol. 1995;26:S452-S455.
82. Modesti PA, Vanni S, Bertolozzi I, et al. Early sequence of cardiac adaptations and growth factor formation in pressure-and volumeoverload hypertrophy. Am J Physiol Heart Circ Physiol. 2000;279: H976-H985.
83. Asano K, Bohlmeyer TJ, Westcott JY, et al. Altered expression of endothelin receptors in failing human left ventricles. J Mol Cell Cardiol. 2002;34:833-846.
84. Ergul A, Grubbs AL, Zhang Y, et al. Selective upregulation of endothelin converting enzyme-1a in the human failing heart. J Card Fail. 2000;6:314-320.
85. Serneri GGN, Cecioni I, Vanni S, et al. Selective upregulation of cardiac endothelin system in patients with ischemic but not idiopathic dilated cardiomyopathy: endothelin-1 system in the human failing heart. Circ Res. 2000;86:377-385.
86. Kakinuma Y, Miyauchi T, Kobayashi T, et al. Myocardial expression of endothelin-2 is altered reciprocally to that of endothelin-1 during ischemia of cardiomyocytes in vitro and during heart failure in vivo. Life Sci. 1999;65:1671-1683.
87. O'Reilly G, Charnock-Jones DS, Morrison JJ, et al. Alternatively spliced mRNAs for human endothelin-2 and their tissue distribution. Biochem Biophys Res Commun. 1993;193:834-840.
88. Plumpton C, Champeney R, Ashby MJ, et al. Characterization of endothelin isoforms in human heart: endothelin-2 demonstrated. J Cardiovasc Pharmacol. 1993;22(suppl 8):S26-S28.
89. Jafri F, Ergul A. Nuclear localization of endothelin-converting enzyme-1: subisoform specificity. Arterioscler Thromb Vasc Biol. 2003;23: 2192-2196.
90. Jafri F, Ergul A. Phosphorylation of endothelin converting enzyme-1 isoforms: relevance to subcellular localization. Exp Biol Med (Maywood). 2006;231:713-717.
91. Malhotra R, Sadoshima J, Brosius FC III, et al. Mechanical stretch and angiotensin II differentially upregulate the renin-angiotensin system in cardiac myocytes in vitro. Circ Res. 1999;85:137-146.
92. Tsai CT, Lai LP, Hwang JJ, et al. Renin-angiotensin system component expression in the HL-1 atrial cell line and in a pig model of atrial fibrillation. J Hypertens. 2008;26:570-582.
93. Clausmeyer S, Reinecke A, Farrenkopf R, et al. Tissue-specific expression of a rat renin transcript lacking the coding sequence for the prefragment and its stimulation by myocardial infarction. Endocrinology. 2000;141: 2963-2970.
94. Dostal DE, Rothblum KN, Conrad KM, et al. Detection of angiotensin I and II in cultured rat cardiac myocytes and fibroblasts. Am J Physiol. 1992;263(4 pt 1):C851-C863.
95. Camargo de Andrade MC, Di Marco GS, de Paulo Castro Teixeira V, et al. Expression and localization of N-domain ANG I-converting enzymes in mesangial cells in culture from spontaneously hypertensive rats. Am J Physiol Ren Physiol. 2006;290:F364-F375.
96. Frustaci A, Kajstura J, Chimenti C, et al. Myocardial cell death in human diabetes. Circ Res. 2000;87:1123-1132.
97. Singh VP, Le B, Bhat VB, et al. High-glucose-induced regulation of intracellular ANG II synthesis and nuclear redistribution in cardiac myocytes. Am J Physiol. 2007;293:H939-H948.
98. Fiordaliso F, Leri A, Cesselli D, et al. Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes. 2001;50: 2363-2375.
99. Singh VP, Baker KM, Kumar R. Activation of the intracellular reninangiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production. Am J Physiol. 2008;294:H1675-H1684.
100. Lavrentyev EN, Estes AM, Malik KU. Mechanism of high glucose induced angiotensin II production in rat vascular smooth muscle cells. Circ Res. 2007;101:455-464.
101. Vidotti DB, Casarini DE, Cristovam PC, et al. High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells. Am J Physiol. 2004;286:F1039-F1045.
102. Baker KM, Chernin MI, Schreiber T, et al. Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy. Regul Pept. 2004;120:5-13.
103. Mazzolai L, Nussberger J, Aubert JF, et al. Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system. Hypertension. 1998;31:1324-1330.
104. Sherrod M, Liu X, Zhang X, et al. Nuclear localization of angiotensinogen in astrocytes. Am J Physiol Regul Integr Comp Physiol. 2005; 288:R539-R546.
105. Singh VP, Le B, Khode R, et al. Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis. Diabetes. 2008;57:3297-3306.
106. Alzayadneh EM, Chappell MC. Nuclear expression of reninangiotensin system components in NRK-52E renal epithelial cells. J Renin Angiotensin Aldosterone Syst. 2014.
107. Abadir PM, Foster DB, Crow M, et al. Identification and characterization of a functional mitochondrial angiotensin system. Proc Natl Acad Sci USA. 2011;108:14849-14854.
108. Hunter AR, Turner AJ. Expression and localization of endothelinconverting enzyme-1 isoforms in human endothelial cells. Exp Biol Med. 2006;231:718-722.
109. Eggena P, Zhu JH, Clegg K, et al. Nuclear angiotensin receptors induce transcription of renin and angiotensinogen mRNA. Hypertension. 1993; 22:496-501.
110. Re R, Parab M. Effect of angiotensin II on RNA synthesis by isolated nuclei. Life Sci. 1984;34:647-651.
111. Li XC, Zhuo JL. Intracellular ANG II directly induces in vitro transcription of TGF-b1, MCP-1, and NHE-3 mRNAs in isolated rat renal cortical nuclei via activation of nuclear AT1a receptors. Am J Physiol Cell Physiol. 2008;294:C1034-C1045.
112. Vaniotis G, Gora S, Nantel A, et al. Examining the effects of nuclear GPCRs on gene expression using isolated nuclei. In: Allen BG, Hébert TE, eds. Nuclear G Protein-coupled Receptors: Methods and Protocols. New York, NY: Springer New York; 2015:185-195.
113. Zhang JH, Barr VA, Mo Y, et al. Nuclear localization of G protein b5 and regulator of G protein signaling 7 in neurons and brain. J Biol Chem. 2001;276:10284-10289.
114. Yamamoto S, Kawamura K, James TM. Intracellular distribution of adenylate cyclase in human cardiocytes determined by electron microscopic cytochemistry. Microsc Res Tech. 1998;40:479-498.
115. Lugnier C, Keravis T, Le Bec A, et al. Characterization of cyclic nucleotide phosphodiesterase isoforms associated to isolated cardiac nuclei. Biochim Biophys Acta. 1999;1472:431-446.
116. Topham MK, Bunting M, Zimmerman GA, et al. Protein kinase C regulates the nuclear localization of diacylglycerol kinase-z. Nature. 1998;394:697-700.
117. Fatima S, Yaghini FA, Ahmed A, et al. CaM kinase IIa mediates norepinephrine-induced translocation of cytosolic phospholipase A2 to the nuclear envelope. J Cell Sci. 2003;116:353-365.
118. Kim CG, Park D, Rhee SG. The role of carboxyl-terminal basic amino acids in Gqa-dependent activation, particulate associate, and nuclear localization of phospholipase C-b1. J Biol Chem. 1996;271: 21187-21192.
119. Faenza I, Matteucci A, Manzoli L, et al. A role for nuclear phospholipase Cb1 in cell cycle control. J Biol Chem. 2000;275:30520-30524.
120. Baldassare JJ, Jarpe MB, Alferes L, et al. Nuclear translocation of RhoA mediates the mitogen-induced activation of phospholipase D involved in nuclear envelope signal transduction. J Biol Chem. 1997;272: 4911-4914.
121. Freyberg Z, Sweeney D, Siddhanta A, et al. Intracellular localization of phospholipase D1 in mammalian cells. Mol Biol Cell. 2001;12: 943-955.
122. Gayral S, Déléris P, Laulagnier K, et al. Selective activation of nuclear phospholipase D-1 by G protein-coupled receptor agonists in vascular smooth muscle cells. Circ Res. 2006;99:132-139.
123. Didichenko SA, Thelen M. Phosphatidylinositol 3-kinase C2a contains a nuclear localization sequence and associates with nuclear speckles. J Biol Chem. 2001;276:48135-48142.
124. Burchett SA. In Through the out door: nuclear localization of the regulators of G protein signaling. J Neurochem. 2003;87:551-559.
125. Scott MG, Le Rouzic E, Perianin A, et al. Differential nucleocytoplasmic shuttling of b-arrestins. Characterization of a leucine-rich nuclear export signal in b-arrestin2. J Biol Chem. 2002;277:37693-37701.
126. Wang P, Wu Y, Ge X, et al. Subcellular localization of b-arrestins is determined by their intact N domain and the nuclear export signal in the C teminus. J Biol Chem. 2003;278:11648-11653.
127. Yi XP, Gerdes AM, Li F. Myocyte redistribution of GRK2 and GRK5 in hypertensive, heart-failure-prone rats. Hypertension. 2002;39: 1058-1063.
128. Yi XP, Zhou J, Baker J, et al. Myocardial expression and redistribution of GRKs in hypertensive hypertrophy and failure. Anat Rec A Discov Mol Cell Evol Biol. 2005;282:13-23.
129. Johnson LR, Scott MG, Pitcher JA. G protein-coupled receptor kinase 5 contains a DNA-binding nuclear localization sequence. Mol Cell Biol. 2004;24:10169-10179.
130. Stehno-Bittel L, Perez-Terzic C, Clapham DE. Diffusion across the nuclear envelope inhibited by depletion of the nuclear Ca2+ store. Science. 1995;270:1835-1838.
131. Lanini L, Bachs O, Carafoli E. The calcium pump of liver nuclear membrane is identical to that of endoplasmic reticulum. J Biol Chem. 1992;267:11548-11552.
132. Abrenica B, Gilchrist JSC. Nucleoplasmic Ca2+ loading is regulated by mobilization of perinuclear Ca2+. Cell Calcium. 2000;28:127-136.
133. Guihard G, Proteau S, Rousseau E. Does the nuclear envelope contain two types of ligand-gated Ca2+ release channels? FEBS Lett. 1997;414: 89-94.
134. Bare DJ, Kettlun CS, Liang M, et al. Cardiac type 2 inositol 1,4,5-trisphosphate receptor: interaction and modulation by calcium/calmodulin-dependent protein kinase II. J Biol Chem. 2005;280: 15912-15920.
135. Bootman MD, Fearnley C, Smyrnias I, et al. An update on nuclear calcium signaling. J Cell Sci. 2009;122(pt 14):2337-2350.
136. Ibarra C, Vicencio JM, Varas-Godoy M, et al. An integrated mechanism of cardiomyocyte nuclear Ca2+ signaling. J Mol Cell Cardiol. 2014;75: 40-48.
137. Wu X, Zhang T, Bossuyt J, et al. Local InsP3-dependent perinuclear Ca2+ signaling in cardiac myocyte excitation-transcription coupling. J Clin Invest. 2006;116:675-682.
138. Raben DM, Jarpe MB, Leach KL. Nuclear lipid metabolism in NEST: nuclear envelope signal transduction. Membr Biol. 1994;142:1-7.
139. Irvine RF. Nuclear lipid signaling. Sci STKE. 2002;150:RE13.
140. Muralidharan S, Nerbonne JM. Photolabile "caged" adrenergic receptor agonists and related model compounds. J Photochem Photobiol B. 1995;27:123-137.
141. Chatenet D, Bourgault S, Fournier A. Design and application of lightactivated probes for cellular signaling. In: Allen BG, Hébert TE, eds. Nuclear G Protein-coupled Receptors: Methods and Protocols. New York, NY: Springer New York; 2015:17-30.